ENSC: Ensysce Continues to Progress in Fight Against Opioids
By Brad Sorensen, CFA
NASDAQ:ENSC
READ THE FULL ENSC RESEARCH REPORT
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 505 companies set new 52-week lows.
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
Avenue Therapeutics (NASDAQ:ATXI) stock moved upwards by 17.2% to $0.7 during Friday's after-market session. The company's market cap stands at $14.5 million.
52 Biggest Movers From Yesterday
Gainers
Zogenix, Inc. (NASDAQ: ZGNX) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion.
35 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Zogenix, Inc. (NASDAQ: ZGNX) shares jumped 67.1% to $26.15 after the company announced it will be acquired by UCB for approximately $1.9 billion.
Ensysce Biosciences Announces First Cohort Dosing In Bioequivalence Study Of Novel ‘TAAP’ Opioid
Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC, OTC:ENSCW), a clinical-stage biotech company with two novel technology platforms designed to provide relief for those suffering
56 Biggest Movers From Friday
Gainers
Hour Loop, Inc. (NASDAQ: HOUR) shares jumped 99.8% to $7.99 after the company priced its IPO at $4 per share.